The following is a transcript of the “Ozempic has changed the game forever. What does it do?” video posted on YouTube.
Ozempic has been a game changer in diabetes and obesity medicine, and you’ve probably heard about it. It was first approved by the FDA for diabetes management back in 2017, and up from that point, it was basically minding its own business, doing a lot of really great things for individuals who had diabetes. But then, in 2021, we got the publication of the STEP 1 trial.
Ozempic’s Jaw-Dropping Impact on Weight Loss
So what happened in the STEP 1 trial is they had a group of individuals that were overweight or obese, and what they did was they split them to either get the placebo, to get Ozempic or the molecule in Ozempic called Semaglutide for a 68-week period. They aimed to see how much weight the individuals on Semaglutide would lose compared to the placebo. And to say that the results weren’t shocking would be an understatement.
They found that over 68 weeks, the individuals taking Semaglutide at a dose of 2.4 milligrams once per week lost, on average, 15% of their weight from baseline. To give you an example, if you currently weigh 200 pounds and lose 15% of your weight from baseline, you would lose about 30 pounds.
From there, the popularity of Ozempic exploded, but it wasn’t for diabetes management:
“weight loss, weight loss, easy weight loss miracle diet drug, miracle weight loss drug.”
So everybody and their dog wanted to be on Ozempic and heck, even I jumped on the train. I made this video in 2021, and to date, it is one of my most popular videos on YouTube.
Unfortunately, the unprecedented demand for Ozempic ultimately led to global shortages, including here in Canada, where the first official shortage of Ozempic has now been announced. But for those of you who might not know, what exactly does Ozempic do? Ozempic is what we call a GLP-1 receptor agonist. It mimics the hormone that our body naturally produces called GLP-1.
Your Body’s Mighty Messengers for Optimal Function
GLP-1 is a hormone, and hormones are kind of like tiny little carrier pigeons. These hormones travel throughout your body, and when they get to their destination, they exert some kind of effect to change your physiology or whatever’s happening at that point in your body. It could be things like increasing your heart rate, improving digestion, you name it. They do everything to keep you alive and functioning.
The receptors, or destinations of the GLP-1 hormone, are found throughout the body, including within your stomach, pancreas, liver, and brain. Now, when you eat a meal, the GLP-1 hormone gets released. It gets released at this point because the GLP-1 hormone is a satiety hormone.
It is a hormone that tells us when we are full and when to stop eating. If you’ve just eaten a meal, that hormone gets released and tells the body, hey, we’re good; we don’t need to eat anymore.
Insulin Boost and Glucagon Control
In the course of its actions, it does a couple of other things, too, for managing diabetes. What it does is it goes to your pancreas, and it tells your pancreas or helps it increase insulin production. Insulin is a hormone that helps to bring your blood sugar levels down and helps to keep them at a reasonable level. It also decreases the production of a hormone called Glucagon.
GLP-1’s Influence on Food Desire and Weight Management
Exploring the Global Drug Shortages
In fact, we have 20-plus years with these drugs to show that they’re safe. They do what they do and don’t cause any long-term complications. Now, of course, they’re not without side effects that can potentially happen, including nausea, heartburn, vomiting, diarrhea, or constipation. The second reason why this drug is so popular is because it works. It really works. Like, It works a 15% weight loss from baseline.
The Future of Obesity Medicine
So Ozempic, from the FDA, has the indication for diabetes management, whereas Wegovy, the exact same molecule in Ozempic, has the indication for the management of obesity. The reality of the matter is that Ozempic and Wegovy, they’re just the start.
So that is it for today, you beautiful people. Be sure to stay tuned on my channel as I talk more about Ozempic and the other molecules coming to market. And definitely, if you’ve got value from this video, hit that subscribe button, hit that like button, and feel free to share it with someone who might need to watch it.
And as always, don’t forget that small tweaks lead to massive peaks.
References:
John P H Wilding, Rachel L Batterham, Salvatore Calanna, Melanie Davies, Luc F Van Gaal, Ildiko Lingvay, Barbara M McGowan, Julio Rosenstock, Marie T D Tran, Thomas A Wadden, Sean Wharton, Koutaro Yokote, Niels Zeuthen, Robert F Kushner; STEP Study Group. (March 18, 2021). Pub Med. Once-Weekly Semaglutide in Adults with Overweight or Obesity. Retrieved by: https://pubmed.ncbi.nlm.nih.gov/33567185/
Follow me on social media for regular updates – @TheOfficialDrDan
Subscribe to my newsletter for a heads-up on all new content.
Sharing is caring! Here’s the social, email, and even text link – https://healthevolved.co/Ozempic-game-changer
If you need some coaching support on your weight management journey, you can book a consultation with me to see if you’d be a good fit for our program.
Questions or comments? Please send them my way on our Contact Us page!